Literature DB >> 7228403

Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment.

J Storz, R Rott, G Kaluza.   

Abstract

Plaque formation, replication, and related cytopathic functions of the enteropathogenic bovine coronavirus strain L9 in bovine fetal thyroid (BFTy) and bovine fetal brain (BFB) cells were investigated in the presence and absence of trypsin. Plaque formation was enhanced in both cell types. Plaques reached a size with an average diameter of 5 mm within 4 days with trypsin in the overlay, whereas their diameter remained less than 1 mm at this time after plating without trypsin in the overlay. Fusion of both cell types was observed 12 to 18 h after infection when trypsin was present in the medium. Fusion was not observed in infected BFB cell cultures and was rarely observed 48 h after infection of BFTy cells maintained with the trypsin-free medium. The largest polycaryons formed had 15 to 22 nuclei. They then lysed and detached. Cell fusion depended on de novo synthesis of hemagglutinin and infectivity. Fusion from without was not observed. Virus produced under trypsin-enhancing conditions accompanied by cell fusion did not lyse mouse erythrocytes that reacted with L9 coronavirus hemagglutinin. Trypsin-treated, infected BFTy cultures produced coronaviral particles that excluded stain from the envelope confinement. These virions had uniformly shorter surface projections than did the viral forms generated by trypsin-free cell cultures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7228403      PMCID: PMC351445          DOI: 10.1128/iai.31.3.1214-1222.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Detection of coronavirus strain 692 by immune electron microscopy.

Authors:  A Z Kapikian; H D James; S J Kelly; A L Vaughn
Journal:  Infect Immun       Date:  1973-01       Impact factor: 3.441

2.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

3.  Restoration of the fusion activity of L cell-borne Sendai virus by trypsin.

Authors:  M Homma; S Tamagawa
Journal:  J Gen Virol       Date:  1973-06       Impact factor: 3.891

4.  Trypsin action on the growth of Sendai virus in tissue culture cells. II. Restoration of the hemolytic activity if L cell-borne Sendai virus by trypsin.

Authors:  M Homma
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

5.  Plaque formation by influenza viruses in the presence of trypsin.

Authors:  G Appleyard; H B Maber
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

6.  Coronavirus propagated from patient with non-bacterial gastroenteritis.

Authors:  E O Caul; S K Clarke
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

7.  Structural polypeptides of the murine coronavirus JHM.

Authors:  H Wege; H Wege; K Nagashima; V ter Meulen
Journal:  J Gen Virol       Date:  1979-01       Impact factor: 3.891

8.  Coronavirus-like particles in Aboriginals and non-Aboriginals in Western Australia.

Authors:  R D Schnagl; I H Holmes; E M Mackay-Scollay
Journal:  Med J Aust       Date:  1978-03-25       Impact factor: 7.738

9.  Characterization of coronavirus II. Glycoproteins of the viral envelope: tryptic peptide analysis.

Authors:  L S Sturman; K V Holmes
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

10.  I. Structural proteins: effects of preparative conditions on the migration of protein in polyacrylamide gels.

Authors:  L S Sturman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

View more
  49 in total

1.  Comparison of the nucleotide and deduced amino acid sequences of the S genes specified by virulent and avirulent strains of bovine coronaviruses.

Authors:  X M Zhang; K G Kousoulas; J Storz
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

2.  Comparison of hemagglutinating, receptor-destroying, and acetylesterase activities of avirulent and virulent bovine coronavirus strains.

Authors:  J Storz; X M Zhang; R Rott
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Bovine coronavirus antigen in the host cell plasmalemma.

Authors:  H R Payne; J Storz; W G Henk
Journal:  Exp Mol Pathol       Date:  1990-10       Impact factor: 3.362

Review 4.  Parallel mechanisms in neuropathogenesis of enteric virus infections.

Authors:  L A Morrison; B N Fields
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells.

Authors:  D W Yoo; M D Parker; L A Babiuk
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

6.  Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice.

Authors:  D M Bass; D Bodkin; R Dambrauskas; J S Trier; B N Fields; J L Wolf
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.

Authors:  D Yoo; D Deregt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

8.  Antibody responses of cattle with respiratory coronavirus infections during pathogenesis of shipping fever pneumonia are lower with antigens of enteric strains than with those of a respiratory strain.

Authors:  Xiao-Qing Lin; Kathy L O'Reilly; Johannes Storz
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Studies of enteric coronaviruses in a feline cell line.

Authors:  R D Woods
Journal:  Vet Microbiol       Date:  1982-11       Impact factor: 3.293

10.  Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.

Authors:  Yiu-Wing Kam; Yuushi Okumura; Hiroshi Kido; Lisa F P Ng; Roberto Bruzzone; Ralf Altmeyer
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.